10X Genomics

56 articles with 10X Genomics

• 10x Genomics Showcases New Solutions at ASHG 2018

  10/16/2018

  Introduces significant advances to its flagship Single Cell Gene Expression Solution

• 

  As San Francisco Real Estate Prices Spiral, Some Biotechs Look to the 'Burbs

  9/20/2018

  The two biggest areas for biotech startups in the U.S. are Cambridge in Boston and the San Francisco Bay Area. They’re also the locations of astonishingly expensive real estate. But they’re where biotechs seem to want to be because they’re close to talent, academic research institutions, and the ...

• 10x Genomics Acquires Epinomics

  8/28/2018

  10X Genomics, a leader in the genomics field, today announced its first acquisition with Epinomics , a pioneer in the growing epigenetics space.

• 10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

  7/31/2018

  The newly developed applications have potential to accelerate disease research and drug discovery in oncology, neurology, infections disease, and immunology in addition to enhancing cell atlas research initiatives.

• 10x Genomics Extends their Application Portfolio with the Launch of Single Cell Mouse Immune Profiling Solution

  6/20/2018

  New solution characterizes single cell gene expression and paired receptor sequences of T- and B-cells in mouse models of disease

• Jean Philibert Joins 10x Executive Management as Chief People Officer

  6/14/2018

  Philibert will focus on cultivating a culture of innovation and excellence for 10x Genomics employees worldwide.

• 

  Foresite Capital Launches New Venture Capital Fund Worth $668 Million

  5/3/2018

  Venture capital firm Foresite Capital, located in San Francisco, is launching a new fund, its fourth and largest, worth $668 million.

• 10x Genomics Completes $50 Million Series D Financing and $75M Credit Facility

  4/26/2018

  The funding was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity and the SoftBank Group.

• 10x Genomics Expands Offering by Launching New Single Cell Solution Focused on DNA

  4/13/2018

  - Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week. -

• 10x Genomics Becomes a Partner in the CanSeq150 Initiative

  4/5/2018

  —CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes—

• 10x Genomics Joins EMBL’s Corporate Partnership Program

  2/21/2018

  10X Genomics., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory.

• 10x Genomics Announces New Partnership Programs

  2/12/2018

  10x Genomic today announced a global partnership ecosystem to accelerate customer adoption of 10x Genomics' sequencing applications through the Certified Service Provider and 10x Compatible Programs.

• 10x Genomics Accelerates Plant and Animal Research with Supernova 2.0

  1/15/2018

  10x Genomics today launched a new version of their de novo assembly solution to provide the fastest most cost-effective solution for creating high-quality de novo assemblies at scale for plants and animals.

• MGI Genetic Sequencer Certified in New 10x Genomics Compatible Program

  1/8/2018

  10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program.

• 10x Genomics Announces Collaboration with Berry Genomics to Develop Next Generation Noninvasive Prenatal Testing (NIPT)

  1/8/2018

  The parties will collaborate to enable a new service offering for Berry Genomics.

• 10X Genomics Seeking Scientists Interested in Expanding the Boundaries of Genomics Technology

  12/11/2017

  Although primarily supported for human samples, scientists in the Genomics Laboratory at the David H. Murdock Research Institute are receiving requests to use the Chromium Controller and Solutions offered by 10X Genomics for everything from plants to marine animals.

• Intermountain Healthcare Announces Precision Health Research Endeavors With 10x Genomics

  10/18/2017

  Intermountain Precision Genomics and 10x Genomics announced today, the addition of Chromium Genome Solution to the Translational Science Center (TSC).

• 10x Genomics Enables High-Volume Studies By Providing More Affordable Solutions For Whole Genome And Exome Analysis

  10/18/2017

  10x Genomics announced more affordable pricing for their Chromium Genome, Exome and de novo Assembly Solutions.

• 10x Genomics and the Human Cell Atlas International Consortium Announce Partnership

  10/16/2017

  10x Genomics and the Human Cell Atlas international consortium today announced a partnership agreement to help enable pilot projects of the Human Cell Atlas project,

• 10X Genomics Announces Automated Workflow For Dried Blood Spot And Saliva For Linked-Read Sequencing

  10/12/2017